Intra-Cellular Therapies, Inc. (ITCI)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,021	8,855	6,893	5,012	4,264	2,549
Market Cap Growth	-	28.46%	37.53%	17.54%	67.27%	34.44%
Enterprise Value	13,037	7,866	6,417	4,409	3,813	1,856
Last Close Price	131.87	83.52	71.62	52.92	52.34	31.80
PS Ratio	19.97	13.01	14.84	20.02	50.88	111.74
PB Ratio	12.20	7.71	11.65	7.64	10.20	3.88
P/TBV Ratio	12.21	7.71	11.65	7.64	10.20	3.88
EV/Sales Ratio	19.15	11.55	13.82	17.62	45.50	81.37
Debt / Equity Ratio	0.02	0.02	0.03	0.03	0.06	0.04
Asset Turnover	0.65	0.65	0.63	0.40	0.14	0.05
Inventory Turnover	15.45	15.45	12.03	9.74	12.91	-
Quick Ratio	5.70	5.70	4.97	8.01	8.11	18.13
Current Ratio	6.36	6.36	5.41	8.87	8.76	18.75
Return on Equity (ROE)	-8.58%	-8.58%	-22.39%	-47.72%	-52.87%	-53.30%
Return on Assets (ROA)	-6.96%	-6.96%	-13.43%	-26.47%	-29.58%	-29.84%
Return on Invested Capital (ROIC)	-8.22%	-8.22%	-15.51%	-29.44%	-31.62%	-31.97%
Earnings Yield	-0.53%	-0.84%	-2.03%	-5.11%	-6.66%	-8.91%
FCF Yield	-0.52%	-0.83%	-1.81%	-5.41%	-6.09%	-9.04%
Buyback Yield / Dilution	-7.56%	-7.56%	-1.95%	-15.75%	-15.47%	-27.50%

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q